EndoShape, Inc.
Biotechnology company · Boulder, Colorado, United States
EndoShape, Inc. is a biotechnology company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2006. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $123,646 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2017.
EndoShape at a glance
What does EndoShape do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $123,646 in total (2021). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $10.5 million sold (2017).
Frequently asked questions about EndoShape
Where is EndoShape headquartered?
EndoShape, Inc. is headquartered in Boulder, Colorado, United States.
What does EndoShape do?
EndoShape, Inc. is a biotechnology company.
When was EndoShape founded?
The earliest incorporation on record for EndoShape, Inc. is in 2006, according to public company registers.
Similar companies
- MBio Diagnostics, Inc.Boulder, Colorado, United States
- InDevR, Inc.Boulder, Colorado, United States
- Fresh Tracks Therapeutics, Inc.Boulder, Colorado, United States
- Lazzaro Medical, Inc.Boulder, Colorado, United States
- AmideBio, LLCBoulder, Colorado, United States
- Orbit Genomics, Inc.Boulder, Colorado, United States
- Crestone, Inc.Boulder, Colorado, United States
- Enveda Therapeutics, Inc.Boulder, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences